semaglutide covered by medi cal Ozempic will no longer be Medi-Cal after GLP-1 drugs cut from California's 2025–26 health budget Medi-Cal Ozempic Coverage for Weight

While the WHO decided not to recommend GLP-1 agonists for diabetes treatment in its 2023 Essential Medicines List (EML), it is likely that they will be recommended in the 2025 update, following an expert committee meeting in May

This is the kind of annual review I do with every Medicare client I work with in Washington State

It mimics GLP-1, a natural hormone that helps regulate hunger, digestion, and blood sugar levels, improving metabolic health and reducing liver fat

According to the Wegovy Summary of Product Characteristics (SmPC), there are no specific food interactions with this medication, meaning no foods are strictly forbidden whilst using this weight management treatment